Cargando…
Parkia speciosa Hassk. Empty Pod Extract Prevents Cardiomyocyte Hypertrophy by Inhibiting MAPK and Calcineurin-NFATC3 Signaling Pathways
Cardiac hypertrophy is an early hallmark during the clinical course of heart failure. Therapeutic strategies aiming to alleviate cardiac hypertrophy via the mitogen-activated protein kinase (MAPK)/calcineurin-nuclear factor of activated T-cells (NFAT) signaling pathway may help prevent cardiac dysfu...
Autores principales: | Mustafa, Nor Hidayah, Jalil, Juriyati, Saleh, Mohammed S. M., Zainalabidin, Satirah, Asmadi, Ahmad Yusof, Kamisah, Yusof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864749/ https://www.ncbi.nlm.nih.gov/pubmed/36675993 http://dx.doi.org/10.3390/life13010043 |
Ejemplares similares
-
Parkia speciosa Hassk. Empty Pod Extract Alleviates Angiotensin II-Induced Cardiomyocyte Hypertrophy in H9c2 Cells by Modulating the Ang II/ROS/NO Axis and MAPK Pathway
por: Siti, Hawa Nordin, et al.
Publicado: (2021) -
UPLC-MS-Based Metabolomics Profiling for α-Glucosidase Inhibiting Property of Parkia speciosa Pods
por: Saleh, Mohammed S. M., et al.
Publicado: (2021) -
Genus Parkia: Phytochemical, Medicinal Uses, and Pharmacological Properties
por: Saleh, Mohammed S. M., et al.
Publicado: (2021) -
Parkia speciosa Hassk.: A Potential Phytomedicine
por: Kamisah, Yusof, et al.
Publicado: (2013) -
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)